Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.055
+0.045 (4.46%)
At close: Jul 26, 2024, 3:59 PM
1.030
-0.025 (-2.37%)
After-hours: Jul 26, 2024, 5:25 PM EDT

Oragenics Revenue

Oragenics had revenue of $20.63K in the twelve months ending March 31, 2024, down -84.54% year-over-year. In the year 2023, Oragenics had annual revenue of $37.65K, down -71.37%.

Revenue (ttm)
$20.63K
Revenue Growth
-84.54%
P/S Ratio
285.41
Revenue / Employee
$4,126
Employees
5
Market Cap
5.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202337.65K-93.87K-71.37%
Dec 31, 2022131.52K44.53K51.20%
Dec 31, 202186.99K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 53.73M
Leafly Holdings 40.05M
SunLink Health Systems 35.51M
Biomerica 5.41M
Innovative Eyewear 1.39M
Alaunos Therapeutics 5.00K
Revenue Rankings